Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3 - Concepedia

Concepedia

Publication | Open Access

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

DOI Full Paper Access

21

Citations

25

References

2012

Year

Åsa Alsiö, Karolina Rembeck, Galia Askarieh, Peer Brehm Christensen, Martti Färkkilâ, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Bart L. Haagmans,

Abstract

Reduced bioavailability of interferon and ribavirin along with higher baseline viral load are dominant risk factors for treatment failure in obese patients with chronic hepatitis C.

References

	Year	Citations

Page 1